https://www.selleckchem.com/products/arv471.html
The severe acute respiratory syndrome-2 (SARS-CoV-2) pandemic disrupted medical care for persons with cancer including those with lymphoma. Many professional societies recommend postponing, decreasing, or stopping anti-cancer therapy in selected persons during the pandemic. Although seemingly sensible, these recommendations are not evidence-based and their impact on anxiety and health-related quality-of-life (HRQoL) is unknown. We surveyed 2532 subjects including 1060 persons with lymphoma, 948 caregivers, and 524 normals using a purpose
Like
Comment
Share
